Back

Left bundle branch area pacing optimized cardiac resynchronization therapy ( LOT CRT) -comparative results to a CRT implanted patient population

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Poster session on devices, others Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Peter Ezer

University of Pecs, Pecs (Hungary)

108 More presentations in this session

Presentation thumbnail
Emergency leadless pacing implantation is feasible and safe out-of-hours
Doctor F. O'Rourke (London, GB)
Abstract Slides Video
Presentation thumbnail
Outcomes of subcutaneous implantable cardioverter defibrillators: UK tertiary centre experience
Doctor L. Toon (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of the quality of life of patients with leadless pacing system during 1 year follow-up period
Doctor A. Baimbetov (Almaty, KZ)
Abstract Slides
Presentation thumbnail
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?
Mr C. Israel (Bielefeld, DE)
Abstract Slides Video
Presentation thumbnail
Procedural heart rate variability and its effect on short-term symptoms after cardioneuromodulation procedure
Doctor S. AYGUN (Ankara, TR)
Abstract

Access the full session

Session thumbnail
Poster session on devices, others

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of left bundle branch area pacing and biventricular pacing in patients with class I indication for resynchronization therapy: preliminary results of the prospective randomized study
thumbnail
Congress Presentation
Six-month echocardiographic follow-up of left bundle branch optimized cardiac resynchronization therapy (LOT-CRT) versus traditional CRT
thumbnail
Congress Presentation
Impact of left bundle branch block morphology in predicting response to left bundle branch area pacing for cardiac resynchronization therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources